Yibing Yan

Yibing Yan

UNVERIFIED PROFILE

Are you Yibing Yan?   Register this Author

Register author
Yibing Yan

Yibing Yan

Publications by authors named "Yibing Yan"

Are you Yibing Yan?   Register this Author

32Publications

-Reads

HSP105 recruits protein phosphatase 2A to dephosphorylate β-catenin.

Mol Cell Biol 2015 Apr 2;35(8):1390-400. Epub 2015 Feb 2.

Department of Discovery Oncology, Genentech, Inc., South San Francisco, California, USA

View Article
April 2015

High-throughput detection of clinically relevant mutations in archived tumor samples by multiplexed PCR and next-generation sequencing.

Clin Cancer Res 2014 Apr 26;20(8):2080-91. Epub 2014 Feb 26.

Authors' Affiliations: Departments of Oncology Biomarker Development, Bioinformatics, Structural Biology, and Pathology, Genentech, Inc.; Fluidigm Inc., South San Francisco, California; and Expression Analysis, Durham, North Carolina.

View Article
April 2014

Evaluation and clinical analyses of downstream targets of the Akt inhibitor GDC-0068.

Clin Cancer Res 2013 Dec 18;19(24):6976-86. Epub 2013 Oct 18.

Authors' Affiliations: Oncology Biomarker Development, Portfolio Management and Operations, Translational Oncology, Biostatistics, and Exploratory Clinical Development, Genentech Inc., DNA Way, South San Francisco, California; Experimental Therapeutics, Molecular Pathology, Breast Cancer and Melanoma, Gastrointestinal and Endocrine Tumors Groups, and Medical Oncology Service, Vall d'Hebron Institute of Oncology, Barcelona; Department of Hematology and Medical Oncology, Institute of Health Research INCLIVA, University of Valencia, Valencia, Spain; and Human Oncology and Pathogenesis Program and Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, New York.

View Article
December 2013

Impact of MET expression on outcome in BRAF(V600E/K) advanced melanoma.

Histopathology 2013 Sep 26;63(3):351-61. Epub 2013 Jun 26.

Product Development-Oncology, Genentech Inc., South San Francisco, CA, USA.

View Article
September 2013

FOXO3a and β-catenin co-localization: double trouble in colon cancer?

Nat Med 2012 Jun 6;18(6):854-6. Epub 2012 Jun 6.

View Article
June 2012

Proteomic analysis of breast cancer molecular subtypes and biomarkers of response to targeted kinase inhibitors using reverse-phase protein microarrays.

Mol Cancer Ther 2008 Dec 3;7(12):3695-706. Epub 2008 Dec 3.

Department of Development Oncology Diagnostics, Genentech, Inc., South San Francisco, California 94080, USA.

View Article
December 2008

Endothelial expression of constitutively active Notch4 elicits reversible arteriovenous malformations in adult mice.

Proc Natl Acad Sci U S A 2005 Jul 30;102(28):9884-9. Epub 2005 Jun 30.

Pacific Vascular Research Laboratory, Division of Vascular Surgery, Department of Surgery and Department of Anatomy, University of California-San Francisco, San Francisco, CA 94143, USA.

View Article
July 2005

Aspirin response and failure in diabetic patients with cardiovascular disease.

Curr Opin Pharmacol 2005 Apr;5(2):190-7

Portola Pharmaceuticals Inc, 270 E. Grand Avenue, Suite 22, South San Francisco, California 94080, USA.

View Article
April 2005

The platelet CD40L/GP IIb-IIIa axis in atherothrombotic disease.

Curr Opin Hematol 2003 Sep;10(5):356-61

Cardiovascular Biology, Millennium Pharmaceuticals Inc., 256 E. Grand Avenue, S. San Francisco, CA 94080, USA.

View Article
September 2003

The metalloprotease Kuzbanian (ADAM10) mediates the transactivation of EGF receptor by G protein-coupled receptors.

J Cell Biol 2002 Jul 15;158(2):221-6. Epub 2002 Jul 15.

Department of Anatomy, University of California-San Francisco, 513 Parnassus Avenue, San Francisco, CA 94143, USA.

View Article
July 2002